Akabani, G., Rizzieri, D. A., Zalutsky, M. R., Coleman, R. E., Metzler, S. D., Bowsher, J. E., … Bigner, D. D. (2004). Phase I trial study of [131]I-labeled chimeric 81C6 mAb for the treatment of patients with non-Hodgkin's lymphoma. In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (Vol. 31, pp. S222–S222). Helsinki, FINLAND: SPRINGER.

Akabani, G., D. A. Rizzieri, M. R. Zalutsky, R. E. Coleman, S. D. Metzler, J. E. Bowsher, B. Toaso, et al. “Phase I trial study of [131]I-labeled chimeric 81C6 mAb for the treatment of patients with non-Hodgkin's lymphoma.” In EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 31:S222–S222. SPRINGER, 2004.

Akabani G, Rizzieri DA, Zalutsky MR, Coleman RE, Metzler SD, Bowsher JE, et al. Phase I trial study of [131]I-labeled chimeric 81C6 mAb for the treatment of patients with non-Hodgkin's lymphoma. In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2004. p. S222–S222.

Akabani, G., et al. “Phase I trial study of [131]I-labeled chimeric 81C6 mAb for the treatment of patients with non-Hodgkin's lymphoma.” EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, vol. 31, SPRINGER, 2004, pp. S222–S222.

Akabani G, Rizzieri DA, Zalutsky MR, Coleman RE, Metzler SD, Bowsher JE, Toaso B, Lagoo A, Moore JO, Gockerman JP, DeCastro C, Gasparetto C, Chao NJ, Bigner DD. Phase I trial study of [131]I-labeled chimeric 81C6 mAb for the treatment of patients with non-Hodgkin's lymphoma. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. SPRINGER; 2004. p. S222–S222.